Thor Medical ASA
Research Thor Medical ASA (TRMED) on Bullrun: market cap NOK 2.49B. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerTRMED
- ExchangeOL
- CountryNorway
- SectorHealthcare
- IndustryBiotechnology
- CurrencyNOK
- Market capNOK 2.49B
- Financial periodFY2025
- RevenueNOK 400.00K
- Net income-NOK 58.00M
- Free cash flow-NOK 120.60M
Valuation Snapshot
latest market cap is NOK 2.49B.
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2025 | NOK 400.00K | -NOK 58.00M | -NOK 120.60M | n/a | -0.17 | NOK 180.60M | NOK 171.40M | NOK 455.90M |
| FY2024 | NOK 0 | -NOK 42.20M | -NOK 23.80M | n/a | -0.18 | NOK 122.82M | NOK 737.00K | NOK 337.14M |
| FY2023 | NOK 0 | -NOK 26.56M | -NOK 64.09M | n/a | -0.15 | NOK 41.28M | NOK 0 | NOK 271.93M |
| FY2022 | NOK 0 | -NOK 311.24M | -NOK 414.71M | n/a | -2.63 | NOK 96.55M | NOK 159.00K | NOK 63.84M |
| FY2021 | NOK 0 | -NOK 441.30M | -NOK 403.72M | n/a | n/a | NOK 277.71M | n/a | NOK 140.52M |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-08-24 | NOK 2.49B | n/a | n/a | n/a |
About Thor Medical ASA
Thor Medical ASA produces and supplies alpha-particle emitters for cancer therapy in Norway. It offers thorium-228, as well as radium-224 and lead-212 to radiopharmaceutical customers. The company was incorporated in 2009 and is headquartered in Oslo, Norway.
Related stock research
Other Healthcare stocks
Selvaag Bolig ASA (0Q92)
Aqua Bio Technology ASA (ABTEC)
Arcticzymes Technologies ASA (B4V)
Circio Holding ASA (CRNA)
Exact Therapeutics AS (EXTX)
Lytix Biopharma AS (LYTIX)
Nykode Therapeutics ASA (NYKD)
Oncoinvent ASA (ONCIN)
SoftOx Solutions AS (SOFTX)
Zelluna ASA (ZLNA)
Medistim ASA (0OCD)
NORDHEALTH AS NK 1 (6E5)
Frequently asked questions
What is Thor Medical ASA's market cap?
Thor Medical ASA's market capitalization is NOK 2.49B.
What does Thor Medical ASA do?
Thor Medical ASA produces and supplies alpha-particle emitters for cancer therapy in Norway. It offers thorium-228, as well as radium-224 and lead-212 to radiopharmaceutical customers. The company was incorporated in 2009 and is headquartered in Oslo, Norway.